A challenge competition with a total purse of $1 million seeks a new type of face mask that people will be eager to wear to protect against infectious diseases. . . . → Read More: Challenge Seeks Next-Generation Face Mask
|
|||||
|
       
  |
An experimental vaccine to prevent Covid-19 infections, given as a nasal spray, produces immune responses in tests with lab mice. . . . → Read More: Immune Responses Shown in Covid-19 Nasal Vaccine 
A clinical trial began enrolling participants to collect real world evidence on a digital therapy designed to relieve chronic insomnia. . . . → Read More: Trial Underway Assessing Insomnia Therapy App 
HBCUs still hand out more bachelor’s degrees in STEM fields to Blacks than traditionally white institutions, but no longer produce the rates of STEM bachelors they once did. . . . → Read More: HBCUs Still Putting Blacks in STEM 
A clinical trial in Canada is evaluating medical cannabis products as treatments for chronic pain with participants reporting their experiences online. . . . → Read More: Cannabis Assessed for Pain in Real-World Trial 
A group of 23 pharmaceutical companies are creating an investment fund to finance research and development of new drugs to combat antibiotic resistance. . . . → Read More: Pharma Companies Form $1B Antibiotics Fund 
National Institutes of Health is organizing a collection of sites for late-stage clinical trials to test Covid-19 vaccines and antibody treatments. . . . → Read More: NIH Opens Covid-19 Clinical Trial Network 
A biotechnology company is receiving European Commission and French government funds to develop vaccines that protect against all strains of Covid-19 and flu viruses. . . . → Read More: EC, France Fund Universal Covid-19, Flu Vaccines 
Plant scientists in California discovered a natural peptide that stops bacteria from causing citrus greening, a disease destroying citrus crops worldwide. . . . → Read More: Univ. Lab Discovers, Licenses Citrus Disease Treatment 
The federal health preparedness agency is spending more than $2 billion for developers to produce Covid-19 vaccines and treatments now in clinical trials. . . . → Read More: BARDA to Buy $2B in Covid-19 Vaccines, Therapies |
||||
|
Copyright © 2020 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
